Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

XBIT – XBiotech Inc.

XBiotech Inc.
XBIT
$2.88
Name : XBiotech Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $87,804,576.00
EPSttm : -1.26
finviz dynamic chart for XBIT
XBiotech Inc.
$2.88
3.36%
$0.1

Float Short %

4.61

Margin Of Safety %

Put/Call OI Ratio

0.06

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

2.9

Target Price

28

Analyst Recom

3

Performance Q

-10.56

Relative Volume

0.71

Beta

1

Ticker: XBIT




22 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-04-15XBIT3.190.103.3386
2025-04-16XBIT2.960.74999.99136
2025-04-17XBIT2.930.74999.99136
2025-04-18XBIT2.940.74999.99136
2025-04-21XBIT2.970.74999.99136
2025-04-22XBIT3.120.74999.99136
2025-04-23XBIT3.110.74999.99136
2025-04-24XBIT2.96N/AN/A0
2025-04-25XBIT2.91N/AN/AN/A
2025-04-28XBIT2.88N/AN/AN/A
2025-04-29XBIT2.87N/AN/A0
2025-04-30XBIT3.08N/AN/A0
2025-05-01XBIT2.94N/AN/A0
2025-05-02XBIT2.93N/AN/A0
2025-05-05XBIT2.85N/AN/A0
2025-05-06XBIT2.77N/AN/A0
2025-05-07XBIT2.76N/AN/A0
2025-05-08XBIT2.87N/AN/A0
2025-05-09XBIT2.84N/AN/A0
2025-05-12XBIT2.9N/AN/A0
2025-05-13XBIT2.960.060.0067
2025-05-14XBIT2.890.060.0073
DateSymbolLastP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-04-15XBIT3.18- - -
2025-04-16XBIT2.97- - -
2025-04-17XBIT2.94- - -
2025-04-18XBIT2.94- - -
2025-04-21XBIT2.97- - -
2025-04-22XBIT3.12- - -
2025-04-23XBIT3.16- - -
2025-04-24XBIT2.96- - -
2025-04-25XBIT2.91- - -
2025-04-28XBIT2.88- - -
2025-04-29XBIT2.87- - -
2025-04-30XBIT3.04- - -
2025-05-01XBIT2.93- - -
2025-05-02XBIT2.92- - -
2025-05-05XBIT2.85- - -
2025-05-06XBIT2.77- - -
2025-05-07XBIT2.79- - -
2025-05-08XBIT2.83- - -
2025-05-09XBIT2.84- - -
2025-05-12XBIT2.91- - -
2025-05-13XBIT2.98- - -
2025-05-14XBIT2.90- - -
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-04-15XBIT0.00-2.993.97
2025-04-16XBIT0.00-2.993.97
2025-04-17XBIT0.00-2.993.97
2025-04-18XBIT0.00-2.993.97
2025-04-21XBIT0.00-2.963.97
2025-04-22XBIT0.00-2.963.97
2025-04-23XBIT0.00-2.963.97
2025-04-24XBIT0.00-2.963.97
2025-04-25XBIT0.00-2.963.97
2025-04-28XBIT0.00-2.963.58
2025-04-29XBIT0.00-2.963.58
2025-04-30XBIT0.00-2.963.58
2025-05-01XBIT0.00-2.963.58
2025-05-02XBIT0.00-2.963.58
2025-05-05XBIT0.00-3.293.58
2025-05-06XBIT0.00-3.293.58
2025-05-07XBIT0.00-3.293.58
2025-05-08XBIT0.00-3.293.58
2025-05-09XBIT0.00-3.293.58
2025-05-12XBIT0.00-4.414.61
2025-05-13XBIT0.00-4.414.61
2025-05-14XBIT0.00-4.414.61
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-4.41

Beta

1

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

19

Growth Score

Sentiment Score

77

Actual DrawDown %

86.5

Max Drawdown 5-Year %

-84.8

Target Price

28

P/E

Forward P/E

PEG

P/S

P/B

0.48

P/Free Cash Flow

EPS

-1.26

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.71

Return on Equity vs Sector %

-44.8

Return on Equity vs Industry %

-28

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

XBiotech Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 92
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes true human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
stock quote shares XBIT – XBiotech Inc. Stock Price stock today
news today XBIT – XBiotech Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch XBIT – XBiotech Inc. yahoo finance google finance
stock history XBIT – XBiotech Inc. invest stock market
stock prices XBIT premarket after hours
ticker XBIT fair value insiders trading